Science-advisor
REGISTER info/FAQ
Login
username
password
     
forgot password?
register here
 
Research articles
  search articles
  reviews guidelines
  reviews
  articles index
My Pages
my alerts
  my messages
  my reviews
  my favorites
 
 
Stat
Members: 3643
Articles: 2'488'730
Articles rated: 2609

29 March 2024
 
  » pubmed » pmid15905366

 Article overview


Patient-specific embryonic stem cells derived from human SCNT blastocysts
Woo Suk Hwang ; Sung Il Roh ; Byeong Chun Lee ; Sung Keun Kang ; Dae Kee Kwon ; Sue Kim ; Sun Jong Kim ; Sun Woo Park ; Hee Sun Kwon ; Chang Kyu Lee ; Jung Bok Lee ; Jin Mee Kim ; Curie Ahn ; Sun Ha Paek ; Sang Sik Chang ; Jung Jin Koo ; Hyun Soo Yoon ; Jung Hye Hwang ; Youn Young Hwang ; Ye Soo Park ; Sun Kyung Oh ; Hee Sun Kim ; Jong Hyuk Park ; Shin Yong Moon ; Gerald Schatten ;
Date 17 Jun 2005
Journal Science, 308 (5729), 1777-83
AbstractPatient-specific, immune-matched human embryonic stem cells (hESCs) are anticipated to be of great biomedical importance for studies of disease and development and to advance clinical deliberations regarding stem cell transplantation. Eleven hESC lines were established by somatic cell nuclear transfer (SCNT) of skin cells from patients with disease or injury into donated oocytes. These lines, nuclear transfer (NT)-hESCs, grown on human feeders from the same NT donor or from genetically unrelated individuals, were established at high rates, regardless of NT donor sex or age. NT-hESCs were pluripotent, chromosomally normal, and matched the NT patient’s DNA. The major histocompatibility complex identity of each NT-hESC when compared to the patient’s own showed immunological compatibility, which is important for eventual transplantation. With the generation of these NT-hESCs, evaluations of genetic and epigenetic stability can be made. Additional work remains to be done regarding the development of reliable directed differentiation and the elimination of remaining animal components. Before clinical use of these cells can occur, preclinical evidence is required to prove that transplantation of differentiated NT-hESCs can be safe, effective, and tolerated.
Source PubMed, pmid15905366 doi: 10.1126/science.1112286
Services Forum | Review | Favorites   
 
Visitor rating: did you like this article? no 1   2   3   4   5   yes

No review found.
 Did you like this article?

This article or document is ...
important:
of broad interest:
readable:
new:
correct:
Global appreciation:

  Note: answers to reviews or questions about the article must be posted in the forum section.
Authors are not allowed to review their own article. They can use the forum section.

browser claudebot






ScienXe.org
» my Online CV
» Free


News, job offers and information for researchers and scientists:
home  |  contact  |  terms of use  |  sitemap
Copyright © 2005-2024 - Scimetrica